Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04832438
Title 9-ING-41 Plus Carboplatin in Patients With Advanced, Metastatic Salivary Gland Carcinoma
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements No
Sponsors Actuate Therapeutics Inc.

salivary gland carcinoma


9-ING-41 + Carboplatin

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.